Skip to main content

Closed

JANX: Janux Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-726.3%

ROIC-16.2%

Financially safe

Stretched

Debt / equity0.02×

Interest coverage0.0×

Current ratio17.01×

Janux Therapeutics, Inc.

JANXNASDAQ Global Market·USD·Closed

Janux Therapeutics, Inc.

JANXNASDAQ·USD·Closed

$15.17

−2.63%

$15.17

−$0.41 (2.63%)

52W Range

13thpctl

Volume

0.46×avg

Mkt Cap

925.13MUSD

P/E

-8.5TTM

Div Yield

–ann

52W Range

13thpctl

Volume

0.46×avg

Market Cap

925.13MUSD

P/E Ratio

-8.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings